Amgen (AMGN) Other Working Capital Changes (2009 - 2026)
Amgen (AMGN) posted quarterly Other Working Capital Changes of $14.0 million for Q1 2011, up 40.0% year-over-year from $10.0 million in Q1 2010, and down 33.33% quarter-over-quarter from $21.0 million in Q4 2010.
Amgen (AMGN) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Amgen's Other Working Capital Changes history runs 3 years deep, the most recent figure standing at $14.0 million for Q1 2011.
- In Q1 2011, Other Working Capital Changes rose 40.0% year-over-year to $14.0 million; the TTM figure through Mar 2011 stood at $144.0 million (down 22.16% YoY), while the FY2010 annual figure was $140.0 million, up 26.13% from the prior year.
- Other Working Capital Changes for Q1 2011 stood at $14.0 million, down from $21.0 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $577.0 million in Q4 2025, with the low at -$241.0 million in Q2 2022.
- The 5-year median for Other Working Capital Changes is $139.0 million (2023), against an average of $130.4 million.
- Peak annual rise in Other Working Capital Changes reached 160.0% in 2010, while the deepest fall reached 34.29% in 2010.
- Amgen's Other Working Capital Changes stood at -$35.0 million in 2009, then jumped by 160.0% to $21.0 million in 2010, then plunged by 33.33% to $14.0 million in 2011.
- Business Quant data shows AMGN's Other Working Capital Changes at $14.0 million in Q1 2011, $21.0 million in Q4 2010, and $47.0 million in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 330.00 Mn |
| Jun 30, 2026 | 330.00 Mn |
| Jun 30, 2026 | 330.00 Mn |
| Mar 31, 2026 | -8.00 Mn |
| Mar 31, 2026 | -8.00 Mn |
| Mar 31, 2026 | -8.00 Mn |
| Dec 31, 2025 | 577.00 Mn |
| Dec 31, 2025 | 577.00 Mn |
| Dec 31, 2025 | 577.00 Mn |
| Sep 30, 2025 | 283.00 Mn |
| Sep 30, 2025 | 283.00 Mn |
| Sep 30, 2025 | 283.00 Mn |
| Jun 30, 2025 | 206.00 Mn |
| Jun 30, 2025 | 206.00 Mn |
| Jun 30, 2025 | 206.00 Mn |
| Mar 31, 2025 | 201.00 Mn |
| Mar 31, 2025 | 201.00 Mn |
| Mar 31, 2025 | 201.00 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Dec 31, 2024 | 14.00 Mn |